Pages that link to "Q36054460"
Jump to navigation
Jump to search
The following pages link to Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses. (Q36054460):
Displaying 50 items.
- Clinical significance of T cell metabolic reprogramming in cancer (Q26741974) (← links)
- Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis (Q26747110) (← links)
- Metabolic communication in tumors: a new layer of immunoregulation for immune evasion (Q26765256) (← links)
- T Cells and Cancer: How Metabolism Shapes Immunity (Q26766427) (← links)
- Starved and Asphyxiated: How Can CD8(+) T Cells within a Tumor Microenvironment Prevent Tumor Progression (Q26767514) (← links)
- Immunometabolism governs dendritic cell and macrophage function (Q26773266) (← links)
- Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents (Q28073524) (← links)
- Immunometabolism of regulatory T cells (Q28074509) (← links)
- PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations (Q28075712) (← links)
- Tumor Microenvironment Metabolism: A New Checkpoint for Anti-Tumor Immunity (Q28077647) (← links)
- The ever-expanding role of HIF in tumour and stromal biology (Q28079015) (← links)
- Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM (Q28394764) (← links)
- Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. (Q30365133) (← links)
- Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy (Q33730033) (← links)
- Glucose represses dendritic cell-induced T cell responses (Q33766590) (← links)
- Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma (Q33798098) (← links)
- Cellular Stress in the Context of an Inflammatory Environment Supports TGF-β-Independent T Helper-17 Differentiation (Q33831578) (← links)
- Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? (Q33917658) (← links)
- Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid Conjugate (Q33918641) (← links)
- The Warburg Effect: How Does it Benefit Cancer Cells? (Q34509467) (← links)
- Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy (Q34522172) (← links)
- Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche. (Q34538613) (← links)
- Cerebral Gluconeogenesis and Diseases (Q34549622) (← links)
- Viral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses (Q35935892) (← links)
- GLUT1 and ASCT2 as Predictors for Prognosis of Hepatocellular Carcinoma (Q36236396) (← links)
- Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis (Q36387235) (← links)
- Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions (Q36789958) (← links)
- ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer. (Q36803802) (← links)
- The multifaceted role of CD4(+) T cells in CD8(+) T cell memory (Q36879974) (← links)
- Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy (Q36988176) (← links)
- Overcoming barriers to effective immunotherapy: MDSCs, TAMs, and Tregs as mediators of the immunosuppressive microenvironment in head and neck cancer. (Q37017190) (← links)
- Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies (Q37058110) (← links)
- Distinctly perturbed metabolic networks underlie differential tumor tissue damages induced by immune modulator β-glucan in a two-case ex vivo non-small-cell lung cancer study (Q37188669) (← links)
- Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors (Q37268993) (← links)
- L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity (Q37359052) (← links)
- Beyond Genomics: Multidimensional Analysis of Cancer Therapy Resistance (Q37407636) (← links)
- Tumor-Induced IL-6 Reprograms Host Metabolism to Suppress Anti-tumor Immunity (Q37409946) (← links)
- S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. (Q37491480) (← links)
- Ionic immune suppression within the tumour microenvironment limits T cell effector function. (Q37548587) (← links)
- Rewiring of embryonic glucose metabolism via suppression of PFK-1 and aldolase during mouse chorioallantoic branching (Q37612814) (← links)
- Tumour microenvironment factors shaping the cancer metabolism landscape. (Q37627771) (← links)
- Nutrient and Metabolic Sensing in T Cell Responses (Q37689449) (← links)
- Heterogeneity in Cancer Metabolism: New Concepts in an Old Field (Q37713095) (← links)
- CCCTC-Binding Factor Translates Interleukin 2- and α-Ketoglutarate-Sensitive Metabolic Changes in T Cells into Context-Dependent Gene Programs. (Q38622052) (← links)
- Immunometabolism: Cellular Metabolism Turns Immune Regulator (Q38624726) (← links)
- Similarities in the Metabolic Reprogramming of Immune System and Endothelium (Q38645730) (← links)
- Cholesterol metabolites and tumor microenvironment: the road towards clinical translation. (Q38662757) (← links)
- Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer (Q38663576) (← links)
- UV-induced somatic mutations elicit a functional T cell response in the YUMMER1.7 mouse melanoma model. (Q38708831) (← links)
- Modulation of Endoplasmic Reticulum Stress Controls CD4+ T-cell Activation and Antitumor Function (Q38713129) (← links)